Combination products with tyrosine kinase inhibitors and their use

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

Tiedt, Ralph,Chatenay-Rivauday, Christian,Ito, Moriko,Peng, Bin,Gong, Ying,Akimov, Mikhail

申请号：

AU2017251741

公开号：

AU2017251741A1

申请日:

2017.10.25

申请国别(地区):

AU

年份:

2017

代理人:

摘要：

#$%^&*AU2017251741A120171116.pdf#####H: rbr Inter n NRPortbl DCC RBR 15893399 1.doex-24/10/2017 ABSTRACT The present invention relates to pharmaceutical products comprising a combination of (i) a MET inhibitor and (ii) an EGFR inhibitor, or a pharmaceutically acceptable salt thereof, respectively, or a prodrug thereof, which are jointly active in the treatment of proliferative diseases, corresponding pharmaceutical formulations, uses, methods, processes, commercial packages and related invention embodiments.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/